- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Atherosclerotic cardiovascular disease with elevated triglycerides
- Meeting Date: November 2023
- Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 1MB)
- Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 321MB)
Icosapent Ethyl – November 2023
Icosapent Ethyl: Capsule 1 g; Vazkepa®
Last updated
15 March 2024